Ultra Botanica LLC

Amerita, Inc, situated in Oklahoma City, OK, specializes in providing expert clinical care and personalized infusion therapy services. Whether at home, in infusion suites, or ambulatory infusion centers nationwide, Amerita is dedicated to delivering exceptional care to patients. Their services encompass a wide range of treatments such as IV antibiotics, immunoglobulin therapy, chronic inflammatory conditions management, specialty medications, nutrition support, clotting factor administration, and inotrope therapy. The team at Amerita consists of highly skilled professionals including pharmacists, nurses, and physicians who work collaboratively to ensure patients receive quality care in a supportive environment. With a focus on individualized care, continuous communication with physicians, and round-the-clock clinical support, Amerita aims to make the infusion therapy process as seamless and stress-free as possible for patients. Their commitment to excellence is evident in their personalized approach and dedication to providing compassionate care. Generated from the website content

Vinyard Fruit & Vegetable in Oklahoma City, OK, is committed to caring for people through food by delivering high-quality, fresh produce and custom solutions tailored to customer needs. With state-of-the-art facilities and a dedicated team, they ensure that all products meet the highest standards of quality and food safety. The company offers a full line of fresh produce, including fresh-cut options, and utilizes centralized shipping and dedicated freight lines for dependable service. Vinyard Fruit & Vegetable proudly emphasizes creativity and agility in addressing the diverse requirements of their clientele. Generated from the website

Biolytx Pharmaceuticals is an emerging drug development company based in Oklahoma City, Oklahoma, dedicated to addressing the crisis of antibiotic drug resistance. Specializing in the advancement of antimicrobial peptide drug candidates, Biolytx focuses on treating serious pathogens that currently lack effective therapeutic options. With a core technology centered around developing novel antibiotic peptides for combating hospital-acquired infections, including those resistant to existing antibiotics, Biolytx aims to progress its pipeline to facilitate collaborations with pharmaceutical companies for clinical trials. Led by CEO Doug Branch, the company's innovative approach targets drug-resistant bacteria, offering potential solutions to critical healthcare challenges.Generated from the website